Bio Essence Corp (BIOE)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

6 annual periodsNewest to oldest
202520242023202220212020
Revenue$1.9M$323,940$551,506$621,590$887,984$958,700
Gross profit$1.4M$217,077$277,446$328,326$298,324$227,287
Operating expenses$528,402$676,515$345,590$839,464$1.2M$1.1M
Operating income$900,011−$459,438−$345,590−$511,138−$857,527−$832,566
EBITDAderived$900,246−$458,527−$340,797−$496,625−$821,725−$799,286
Net income$896,197−$1.3M−$971,879−$809,679−$647,564−$595,838
Basic EPSper diluted share-$0.03-$0.03-$0.02-$0.02-$0.02
Diluted EPSper diluted share-$0.03-$0.03-$0.02-$0.02-$0.02

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys1$2.50M disclosed value
Sells (SEC code S)13$2.98M disclosed value
14 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Oct 30, 2024Form 4Yan YinChief Executive OfficerSellCommon Stock143.8K$0.57$82.0K82.1K
Oct 29, 2024Form 4Yan YinChief Executive OfficerSellCommon Stock40.0K$0.64$25.6K2.6K
Oct 28, 2024Form 4Yan YinChief Executive OfficerSellCommon Stock140.0K$2.48$347.2K345.9K
Sep 30, 2024Form 4Yan YinChief Executive OfficerSellCommon stock2.0K$2.35$4.7K13.68M
Sep 27, 2024Form 4Yan YinChief Executive OfficerSellCommon Stock200$1.69$338.0013.69M